ESC & iPSC News 14.14 April 17, 2019 | |
| |
TOP STORYA Compendium of Mutational Signatures of Environmental Agents Investigators examined mutational signatures in 324 whole-genome-sequencing human-induced pluripotent stem cells exposed to 79 known or suspected environmental carcinogens. Forty-one yielded characteristic substitution mutational signatures. Some were similar to signatures found in human tumors. [Cell] Abstract | Press Release | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells Researchers identified human pluripotent founder cells (PFCs) that initiate, as well as preserve and establish, PSC cultures. PFCs were marked by N-cadherin expression and reside exclusively at the colony boundary of primate PSCs. [Cell] Abstract | Press Release | Graphical Abstract The authors presented engineered mouse ESCs targeting the PRC2 subunits EZH1 and EZH2 to discriminate between contributions of distinct H3K27 methylation states and the presence of PRC2/1 at chromatin. They generated catalytically inactive EZH2 mutant ESCs, demonstrating that H3K27 methylation, but not recruitment to the chromatin, was essential for proper ESC differentiation. [Nat Commun] Full Article MKL1-Actin Pathway Restricts Chromatin Accessibility and Prevents Mature Pluripotency Activation Scientists reported that MKL1, the key transcriptional co-activator of many actin cytoskeletal genes, regulated genomic accessibility and cell fate reprogramming. The MKL1-actin pathway weakened during somatic cell reprogramming by pluripotency transcription factors. [Nat Commun] Full Article Investigators found that the unfolded protein response of the endoplasmic reticulum (UPRER), the mitochondrial UPR, and the heat shock response, which ensured proteome quality during stress, were activated during reprogramming. The UPRER was particularly crucial, and its ectopic, transient activation, genetically or pharmacologically, enhanced reprogramming. [Sci Adv] Full Article The authors interrogated dynamics in chromatin accessibility during differentiation of ESCs to definitive endoderm (END), predicting DNA-binding proteins that may drive this cell fate transition. They then combined single-cell RNA-seq with parallel CRISPR perturbations to comprehensively define the loss-of-function phenotype of those factors in END development. [Cell Rep] Full Article | Graphical Abstract By employing spinner culture, researchers could obtain a >10fold higher yield of cortical interneuron (cIN) progenitors compared to conventional culture without affecting their phenotype. Generated cIN spheres could be maintained feeder-free up to 10 months and were optimized for passaging and cryopreservation. [Mol Ther Methods Clin Dev] Abstract | Full Article Scientists established a model using iPSCs with transcriptome profiles comparable to that of normal fetal brain development. When applied on iPSCs with T21, transcriptome and proteome signatures at two stages of differentiation revealed strong temporal dynamics of dysregulated genes, proteins and pathways belonging to 11 major functional clusters. [Mol Neurobiol] Full Article Hybrid neurovascular spheroids were constructed by fusion of human iPSC-derived cortical neural progenitor cell (iNPC) spheroids, endothelial cell (iEC) spheroids, and the supporting human mesenchymal stem cells (MSCs). Single hybrid spheroids were constructed at different iNPC: iEC: MSC ratios. The incorporation of MSCs upregulated the secretion levels of cytokines VEGF-A, PGE2, and TGF-β1 in hybrid spheroid system. [Sci Rep] Full Article Researchers adapted existing protocols to establish a novel monolayer differentiation protocol for rat ESCs to study X chromosome inactivation. They showed that differentiating rat ESCs properly downregulated pluripotency factor genes, and presented female specific Xist RNA accumulation and silencing of X-linked genes. [Sci Rep] Full Article A commercially available integrin array established by synthetic integrin binding peptides was used to screen coating substrates for iPSCs and NEPs. The authors showed that binding peptides of integrin α5β1, αVβ1, αMβ2 and αIIbβ3 supported cell adhesion of iPSCs, while α5β1, αVβ1 and αIIbβ3 binding peptides supported NEPs adhesion. [Exp Cell Res] Abstract Subscribe to one of our other 19 science newsletters such as Cell Therapy News & Mesenchymal Cell News. | |
| |
REVIEWSAPC/C Ubiquitin Ligase: Coupling Cellular Differentiation to G1/G0 Phase in Multicellular Systems The author reviews recent advances in the function of APC/C in animal development, specifically focusing on its emerging role in regulating cell differentiation. They describe how APC/C regulates distinct processes during the course of differentiation by deploying diverse molecular machineries in a variety of developmental contexts. [Trends Cell Biol] Abstract Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field. | |
| |
SCIENCE NEWSBioTime to Present Data from OpRegen® Phase I/IIa Clinical Study BioTime, Inc. announced that updated results from a Phase I/IIa clinical study of its lead product candidate, OpRegen®, a retinal pigment epithelium cell transplant therapy currently in development for the treatment of dry age-related macular degeneration with geographic atrophy, will be presented. [Press release from BioTime, Inc. discussing research to be presented at the 2019 Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2019), Vancouver] Press Release | |
| |
INDUSTRY NEWSAllele Biotechnology and Pharmaceuticals, Inc. officially announced a joint research and development agreement with SCM Lifescience Co., Ltd., for the development of diabetes therapies using pancreatic beta cells derived from iPSCs. [Allele Biotechnology and Pharmaceuticals, Inc. (Business Wire, Inc.)] Press Release ACEA Biosciences – A Part of Agilent unveiled the new xCELLigence® RTCA ePacer™ during their workshop held at the Society of Toxicology (SOT) Annual Meeting in Baltimore. Human iPSC cardiomyocytes are increasingly being used as a human-relevant in vitro model system for drug discovery, safety pharmacology, and cardiac disease research. [ACEA BIO (Business Wire, Inc.)] Press Release | |
| |
POLICY NEWS‘Friendly’ Reviewers Rate Grant Applications More Highly Peer reviewers are four times more likely to give a grant application an “excellent” or “outstanding” score rather than a “poor” or “good” one when they are chosen by the grant’s applicants, an analysis of Swiss funding applications has found. [Nature News] Editorial Indian Scientists Launch Preprint Repository to Boost Research Quality Researchers in India will soon have their own preprint repository where they can post manuscripts from any discipline. The founders of IndiaRxiv hope it will improve the quality of science in the country. [Nature News] Editorial Stanford Clears Three Faculty Members of ‘CRISPR Babies’ Involvement Stanford University cleared three faculty members of any misconduct in their interactions with the Chinese scientist who created “CRISPR babies” last year. [STAT News] Editorial
| |
EVENTSNEW Germ Cell Programming in Vertebrate Biology, Medicine and Biotechnology Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Lecturer – Stem Cell Biology & Regenerative Medicine (The University of Manchester) Scientist – Stem Cell Metabolism (STEMCELL Technologies Inc.) Scientist – Cell Culture Media and Cell Line Development (STEMCELL Technologies Inc.) Postdoctoral Fellowship – iPSCs and Differentiated Neurons (Howard Hughes Medical Institute) Associate Staff Scientist, Automation Systems (New York Stem Cell Foundation) Director of Operations – Biotech Production (Cincinnati Children’s Hospital Medical Center) Postdoctoral Fellowship – Patient-Derived iPSC Research (Oklahoma Medical Research Foundation) Postdoctoral Fellowship – Human iPSC Research (Emory University) Postdoctoral Fellow – Genetics and Epigenomics of iPSC Biology (Stanford University) Assistant Associate Professor/Professor in Residence – Stem Cell Program (UC Davis) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in ESC & iPSC News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|